Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

NCT06168084 is registered in ClinicalTrials.gov with Yongquan Shi as lead sponsor.

NCT NCT06168084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06168084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Lead sponsor
Yongquan Shi
Phase
Phase 4
Overall status
Completed
Start date
June 6, 2023
Completion date
August 30, 2024
Enrollment
688 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis dyspepsia helicobacter pylori infection gastric cancer peptic ulcer